Neuroleptic malignant syndrome with a positive Weil-Felix test.
D000372:Agglutination Tests; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003168:Complement Fixation Tests; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005334:Fever / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced / Q000175:diagnosis; D011511:Proteus / Q000276:immunology*; D011512:Proteus Infections / Q000175:diagnosis / Q000276:immunology
D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D008094:Lithium